Barriers to Clinical Translation with Diagnostic Drugs
نویسندگان
چکیده
منابع مشابه
Barriers to clinical translation with diagnostic drugs.
Radioactive imaging agents, like diagnostic drugs generally, undergo a drug development process that parallels that of therapeutic agents, with similar development times but substantially lower development costs and substantially smaller postapproval markets. Although rapid advances in genetic and expression profiling are furthering the development of expensive pharmacotherapies targeted to sma...
متن کاملBiologic Drugs, Biosimilars, and Barriers to Entry.
Biologic drugs represent an important new category of drugs in the effort to improve health outcomes in this country. Yet, these cutting-edge drugs are often cost prohibitive, preventing access for many Americans. Recognizing the need for more affordable, generic substitutes for biologic drugs—or biosimilars—Congress recently created a biosimilars approval pathway that would enable these cheape...
متن کاملBarriers to Patient Education in Clinical Care Viewpoints of Nurses
Introduction: Patient education is considered as a standard in quality of nursing care. It is counted as an accrediting criterion for the organizations that provide health services. Meanwhile, there are evidences indicating the failure in this area. As a result, this study aimed to determine barriers to patient education in managerial, individual care-giving, as well as patients and caregivers ...
متن کاملBarriers to knowledge translation: from controlled scenario to clinical scenario in addictions treatment
Background The transfer and translation of programs with scientific evidence to clinical scenarios is often limited by a number of barriers to their implementation [1], making it difficult to provide benefits for a society that requires effective services [2]. The aim of this study was therefore to identify barriers to the adoption of brief intervention programs for the treatment of the abuse o...
متن کاملThe concept of diabetes translation: addressing barriers to widespread adoption of new science into clinical care.
The National Commission on Diabetes (NCD) performed a landmark review of diabetes in the U.S. in 1975 (1). Its four-volume 10-part report contained extensive testimony from all aspects of the diabetic community, including scientists, clinicians, patients, and their families. The NCD promoted a concept that was new to the diabetes field: the concept of translation. The NCD recognized that a sign...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nuclear Medicine
سال: 2013
ISSN: 0161-5505,2159-662X
DOI: 10.2967/jnumed.112.107615